Politwoops
Explore the Tweets They Didn't Want You to See
Politwoops tracks deleted tweets by public officials, including people currently in office and candidates for office.
Politwoops tracks deleted tweets by public officials, including people currently in office and candidates for office. If you think we're missing someone, please email us with their name, state, political party, office they hold or are seeking and, of course, their Twitter handle.
Are your deleted tweets displayed here but you think they shouldn't be? Here's how to let us know.
Hace 61 años #Venezuela derroco una dictadura. Hoy, como aquel #23E de 1952, es un día histórico para los venezolanos quienes marchan en contra de la narco-dictadura de #Maduro y alzan su voz en apoyo al Presidente Provisional de #Venezuela @jguaido.
61 years ago #Venezuela overthrew a dictatorship. Today, just like January 23, 1952, is a historic day for Venezuelans marching against #Maduro’s narco-terrorist tyranny and raising their voice in support of the Provisional President of #Venezuela @jguaido.
SteveFDA (R-D.C.)
@SGottliebFDA
We've advanced a major new modernization of the 510(k) process to enable modern performance standards -- that reflect up-to-date considerations for the safety and utility of medical devices -- to serve as more modern predicates for new 510(k) clearances https://t.co/qLJiQa7dbe
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: THREAD: We announced two more steps in efforts to modernize FDA’s 510(k) path for medical devices.… https://t.co/Vo3SdVi7W4
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RAPSorg: .@US_FDA Finalizes Accelerated Approval Labeling Guidance | #Regulatory Focus https://t.co/VpVzq4zObP #FDA #pharma #biotech
SteveFDA (R-D.C.)
@SGottliebFDA
THREAD: FDA issued new guidance on developing, validating immune tests of therapeutic products during trials. Testing for potential immune responses in CTs provides early info important to inform biological product development programs, incl. biosimilars. https://t.co/It6gsCTfm1
SteveFDA (R-D.C.)
@SGottliebFDA
The clinical effects of patient immune responses are highly variable, ranging from no measurable effect to extremely harmful, so detection and analysis of anti-drug antibody formation is an important tool in understanding these potential patient immune responses
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA remains committed to advancing policies that provide more clarity to therapeutic product developers to make the overall development process more efficient, while maintaining regulatory standards
SteveFDA (R-D.C.)
@SGottliebFDA
During the lapse in funding, #FDA continues to advance certain policy, consistent with what's permissible under law. Like today’s guidance, supported by carryover user-fees
RT @CharlieHannema: Honored to have @GovStitt visit @BASchools today! Join us live on the @BASchools Facebook page for a major announcement at 11 AM! #oklaed https://t.co/Ik2LWHz1Oq
Are your deleted tweets displayed here but you think they shouldn't be? Here's how to let us know.